Put CV Risks With Triptans in Perspective

December 2022

We’re getting questions about which patients should avoid triptans due to cardiovascular concerns.

Labeling says that triptans shouldn’t be used in patients with coronary artery disease, stroke, uncontrolled hypertension, etc.

This stems from the early 1990s when it was thought that MIs were caused by vasospasm. Patients with CV disease or uncontrolled hypertension were excluded from triptan trials.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote